Effectiveness of a family-based health promotion intervention for women with prior GDM: The Face-it RCT
journal contribution
posted on 2025-01-09, 02:25authored byKaroline Kragelund Nielsen, Inger Katrine Dahl-Petersen, Dorte Møller Jensen, Peter Damm, Per Ovesen, Elisabeth R Mathiesen, Ulla Kampmann, Christina Anne Vinter, Sine Knorr, Lise Lotte Andersen, Emma Davidsen, Nanna Husted Jensen, Jori Aalders, Maja Thøgersen, Anne Timm, Henrik Støvring, Helle Terkildsen Maindal
Abstract
Context
Gestational diabetes mellitus (GDM) increases the risk of future type 2 diabetes (T2DM), but effective and feasible interventions to reduce this risk are lacking.
Objective
To evaluate the effectiveness of a family-based health promotion intervention on T2DM risk factors and quality of life among women with recent GDM.
Design
Multicenter, parallel, open-label randomized controlled trial with 2:1 allocation ratio.
Setting
Three sites in Denmark.
Participants
Women diagnosed with GDM.
Intervention(s)
The intervention consisted of (i) home visits with tailored family-based counseling (ii) digital health coaching, (iii) structured cross-sectoral communication.
Main Outcome Measures
Primary outcomes were body mass index (BMI) and quality of life (SF12 MCS) 1-year after delivery.
Results
We randomized 277 women to the intervention (n=184) or usual care group (n=93). The intervention did not result in significantly lower BMI (-0.44 kg/m2; 95%CI -0.98 to 0.11) or higher SF12 MCS (0.06; 95%CI -2.15 to 2.27) compared to the usual care group. A pre-specified post hoc analysis demonstrated a reduced BMI in the intervention group among women with BMI ≥25 kg/m2 (-0.86 kg/m2; (-1.58 to -0.14)).
Analyses of secondary and tertiary outcomes indicated significantly lower 2-h insulin (-94.3 pmmol/L; 95%CI -167.9 to -20.6) and triglycerides (-0.18 mmol/L; 95%CI -0.30 to -0.05) levels, and odds of fasting plasma glucose ≥6·1 mmol/L (OR 0.33; 95%CI 0.12 to 0.91) in the intervention group.
Conclusion
The intervention did not result in lower BMI or increased quality of life, but seemingly reduced other risk factors, and lowered BMI in the subgroup of overweight women.
History
Journal
Journal of Clinical Endocrinology and Metabolism (JCEM)